Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules

Biomaterials

Volumn 35, Issue 27, 2014, Pages 7762-7773

  Rao, Wei ^a,b   Zhao, Shuting ^a,b   Yu, Jianhua ^c,d   Lu, Xiongbin ^e   Zynger, Debra L ^d   He, Xiaoming ^a,b,c  

^a The Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Alginate; Cancer stem like cells; Hydrogel; Microcapsule; Miniaturized 3D culture

Indexed keywords

AGGREGATES; ALGINATE; CELLS; ENCAPSULATION; GENE EXPRESSION; HYDROGELS;

3-D CULTURES; ALGINATE HYDROGELS; CONVENTIONAL APPROACH; CORE-SHELL MICROCAPSULES; HUMAN PROSTATE CANCER CELLS; MICROCAPSULES; PROTEIN EXPRESSIONS; SURFACE RECEPTORS;

DISEASES;

ALGINIC ACID; CD133 ANTIGEN; CELL SURFACE RECEPTOR; GLYCOPROTEIN; HERMES ANTIGEN; HYDROGEL; LEUKOCYTE ANTIGEN; MICROCAPSULE; PEPTIDE;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM LIKE CELL; CANCER THERAPY; CARCINOGENICITY; CELL ENCAPSULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROCAPSULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIDE POPULATION CELL; STEM CELL; ANIMAL; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; KINETICS; METABOLISM; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHARMACOLOGY; PROCEDURES; PROSTATE TUMOR; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CAPSULES; CARCINOGENESIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; HYDROGEL; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; SIDE-POPULATION CELLS; SPHEROIDS, CELLULAR;

EID: 84903440354     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.06.011     Document Type: Article

References (63)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics 2013. CA Cancer J Clin 2013, 63:11-30.
2. Cooperberg M.R., Moul J.W., Carroll P.R. The changing face of prostate cancer. JClin Oncol 2005, 23:8146-8151.
3. Shen M.M., Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Gene Dev 2010, 24:1967-2000.
4. Debes J.D., Tindall D.J. Mechanisms of androgen-refractory prostate cancer. NEngl J Med 2004, 351:1488-1490.
5. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001, 1:34-45.
6. Li H., Tang D.G. Prostate cancer stem cells and their potential roles in metastasis. JSurg Oncol 2011, 103:558-562.
7. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., et al. Acell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
8. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
9. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
10. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. NEngl J Med 2006, 355:1253-1261.
11. Frank N.Y., Schatton T., Frank M.H. The therapeutic promise of the cancer stem cell concept. JClin Invest 2010, 120:41-50.
12. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
13. Yang Z.L., Zheng Q., Yan J., Pan Y., Wang Z.G. Upregulated CD133 expression in tumorigenesis of colon cancer cells. World J Gastroenterol 2011, 17:932-937.
14. Fluri D.A., Tonge P.D., Song H., Baptista R.P., Shakiba N., Shukla S., et al. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat Methods 2012, 9:509-516.
15. Fan X., Liu S., Su F., Pan Q., Lin T. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol 2012, 30:314-318.
16. Frith J.E., Thomson B., Genever P.G. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 2010, 16:735-749.
17. Kelly S.E., Di Benedetto A., Greco A., Howard C.M., Sollars V.E., Primerano D.A., et al. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One 2010, 5:e10035.
18. Goodwin T.J., Prewett T.L., Wolf D.A., Spaulding G.F. Reduced shear stress: a major component in the ability of mammalian tissues to form three-dimensional assemblies in simulated microgravity. JCell Biochem 1993, 51:301-311.
19. Nishida S., Hirohashi Y., Torigoe T., Kitamura H., Takahashi A., Masumori N., et al. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. JUrol 2012, 188:294-299.
20. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., et al. Invitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Gene Dev 2003, 17:1253-1270.
21. Liotta L.A., Kohn E. Anoikis: cancer and the homeless cell. Nature 2004, 430:973-974.
22. Shaw F.L., Harrison H., Spence K., Ablett M.P., Simoes B.M., Farnie G., et al. Adetailed mammosphere assay protocol for the quantification of breast stem cell activity. JMammary Gland Biol Neoplasia 2012, 17:111-117.
23. Yang X., Sarvestani S.K., Moeinzadeh S., He X., Jabbari E. Three-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulus. Tissue Eng Part A 2013, 19:669-684.
24. Feng S., Duan X., Lo P.K., Liu S., Liu X., Chen H., et al. Expansion of breast cancer stem cells with fibrous scaffolds. Integr Biol (Camb) 2013, 5:768-777.
25. Kim J.B. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 2005, 15:365-377.
26. Wilson J.L., McDevitt T.C. Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation. Biotechnol Bioeng 2013, 110:667-682.
27. Hwang N.S., Varghese S., Zhang Z., Elisseeff J. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate modified hydrogels. Tissue Eng 2006, 12:2695-2706.
28. Park H., Temenoff J.S., Tabata Y., Caplan A.I., Mikos A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007, 28:3217-3227.
29. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M.S., De Vos P., et al. Cell encapsulation: promise and progress. Nat Med 2003, 9:104-107.
30. Liu H., Lin J., Roy K. Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells. Biomaterials 2006, 27:5978-5989.
31. Chan C.Y., Huang P.H., Guo F., Ding X., Kapur V., Mai J.D., et al. Accelerating drug discovery via organs-on-chips. Lab Chip 2013, 13:4697-4710.
32. Choi J., Agarwal P., Huang H., Zhao S., He X. The crucial role of mechanical heterogeneity in regulating follicle development and ovulation with engineered ovarian microtissue. Biomaterials 2014, 35:5122-5128.
33. Agarwal P., Zhao S., Bielecki P., Rao W., Choi J.K., Zhao Y., et al. One-step microfluidic generation of pre-hatching embryo-like core-shell microcapsules for miniaturized 3D culture of pluripotent stem cells. Lab Chip 2013, 13:4525-4533.
34. Lee K.Y., Mooney D.J. Alginate: properties and biomedical applications. Prog Polym Sci 2012, 37:106-126.
35. Augst A.D., Kong H.J., Mooney D.J. Alginate hydrogels as biomaterials. Macromol Biosci 2006, 6:623-633.
36. Zhang W., Zhao S., Rao W., Snyder J., Choi J.K., Wang J., et al. Anovel core-shell microcapsule for encapsulation and 3D culture of embryonic stem cells. JMater Chem B Mater Biol Med 2013, 2013:1002-1009.
37. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
38. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia B., Tang S., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
39. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. JCell Sci 2004, 117:3539-3545.
40. Foster B.A., Gangavarapu K.J., Mathew G., Azabdaftari G., Morrison C.D., Miller A., et al. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One 2013, 8:e55062.
41. Uchida N., Dykstra B., Lyons K., Leung F., Kristiansen M., Eaves C. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Blood 2004, 103:4487-4495.
42. Bapat S.A. Human ovarian cancer stem cells. Reproduction 2010, 140:33-41.
43. Naumov G.N., Bender E., Zurakowski D., Kang S.Y., Sampson D., Flynn E., et al. Amodel of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. JNatl Cancer Inst 2006, 98:316-325.
44. Chuthapisith S., Eremin J., El-Sheemey M., Eremin O. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol 2010, 19:27-32.
45. Marotta L.L., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., et al. The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. JClin Invest 2011, 121:2723-2735.
46. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. JClin Invest 2011, 121:3804-3809.
47. Chin A.R., Wang S.E. Cytokines driving breast cancer stemness. Mol Cell Endocrinol 2013, 382:598-602.
48. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7:1028-1034.
49. Jeter C.R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009, 27:993-1005.
50. Yu F., Li J., Chen H., Fu J., Ray S., Huang S., et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.
51. Kumar S.M., Liu S., Lu H., Zhang H., Zhang P.J., Gimotty P.A., et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012, 31:4898-4911.
52. Choi N., Zhang B., Zhang L., Ittmann M., Xin L. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012, 21:253-265.
53. Wang X., Kruithof-de Julio M., Economides K.D., Walker D., Yu H., Halili M.V., et al. Aluminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009, 461:495-500.
54. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146:633-644.
55. Zhang X., Wang W., Yu W., Xie Y., Zhang Y., Ma X. Development of an invitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog 2005, 21:1289-1296.
56. Ma M.Z., Cheng D.F., Ye J.H., Zhou Y., Wang J.X., Shi M.M., et al. Microencapsulated tumor assay: evaluation of the nude mouse model of pancreatic cancer. World J Gastroenterol 2012, 18:257-267.
57. Oldridge E.E., Pellacani D., Collins A.T., Maitland N.J. Prostate cancer stem cells: are they androgen-responsive?. Mol Cell Endocrinol 2012, 360:14-24.
58. Maitland N.J., Collins A.T. Prostate cancer stem cells: a new target for therapy. JClin Oncol 2008, 26:2862-2870.
59. Wang S., Garcia A.J., Wu M., Lawson D.A., Witte O.N., Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci U S A 2006, 103:1480-1485.
60. Su G., Zhao Y., Wei J., Han J., Chen L., Xiao Z., et al. The effect of forced growth of cells into 3D spheres using low attachment surfaces on the acquisition of stemness properties. Biomaterials 2013, 34:3215-3222.
61. Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A., Rodrigues L.O., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 2011, 108:7950-7955.
62. Fillmore C.M., Gupta P.B., Rudnick J.A., Caballero S., Keller P.J., Lander E.S., et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A 2010, 107:21737-21742.
63. Molyneux G., Geyer F.C., Magnay F.A., McCarthy A., Kendrick H., Natrajan R., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010, 7:403-417.